| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2717281 | The American Journal of Medicine | 2009 | 5 Pages |
Abstract
Seniors with asthma or comorbid conditions that are common in the elderly have been systematically excluded from asthma treatment trials. There is no compelling evidence to demonstrate the superiority of any pharmacologic therapy in these asthmatic patients. Evaluation of response to asthma treatment in clinical trials remains primarily symptom-based when symptoms have been shown to underestimate the severity of disease in seniors.
Related Topics
Health Sciences
Medicine and Dentistry
Medicine and Dentistry (General)
Authors
Richard D. MD, J. Eric MD,